Abbott Laboratories (ABT) EBITDA Margin (2009 - 2026)
Abbott Laboratories (ABT) posted EBITDA Margin of 13.44% for Q2 2026, up 11.59% sequentially from 12.05% in Q1 2026, and down 497.0% YoY from 3.39% in Q2 2025.
Abbott Laboratories (ABT) EBITDA Margin (2009 - 2026) Analysis & Trends
Abbott Laboratories has reported EBITDA Margin for 18 years, with the latest figure at 13.44% in Q2 2026.
- Quarterly EBITDA Margin fell 497.0% year-over-year to 13.44% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 15.77% (down 166.0% YoY) and the FY2025 annual result came in at 18.17%, up 190.0% from the prior year.
- EBITDA Margin climbed to 13.44% in Q2 2026 per ABT's latest filing, from 12.05% in the prior quarter.
- Over five years, EBITDA Margin peaked at 24.48% in Q1 2022 and troughed at 12.05% in Q1 2026.
- A 5-year average of 16.83% and a median of 16.67% in 2022 frame the typical range for EBITDA Margin.
- The sharpest annual moves came in 2022 and 2023: EBITDA Margin jumped 749 bps in 2022, then slumped 900 bps in 2023.
- Over 5 years, EBITDA Margin stood at 12.92% in 2022, then soared by 35 bps to 17.38% in 2023, then increased by 0 bps to 17.41% in 2024, then climbed by 13 bps to 19.64% in 2025, then sank by 32 bps to 13.44% in 2026.
- According to Business Quant data, EBITDA Margin over the past three periods registered 13.44%, 12.05%, and 19.64% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 13.44% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 25.18% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 21.65% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 29.48% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 24.33% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 13.96% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 10.30% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 19.15% |
| 10 | Zimmer Biomet Holdings | 19.04 Bn | 18.63 Bn | 1.54 Bn | 14.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.44% |
| Mar 31, 2026 | 12.05% |
| Dec 31, 2025 | 19.64% |
| Sep 30, 2025 | 18.09% |
| Jun 30, 2025 | 18.42% |
| Mar 31, 2025 | 16.34% |
| Dec 31, 2024 | 17.41% |
| Sep 30, 2024 | 17.48% |
| Jun 30, 2024 | 16.08% |
| Mar 31, 2024 | 13.91% |
| Dec 31, 2023 | 17.38% |
| Sep 30, 2023 | 16.24% |
| Jun 30, 2023 | 15.45% |
| Mar 31, 2023 | 15.48% |
| Dec 31, 2022 | 12.92% |
| Sep 30, 2022 | 17.00% |
| Jun 30, 2022 | 21.11% |
| Mar 31, 2022 | 24.48% |
| Dec 31, 2021 | 20.74% |
| Sep 30, 2021 | 23.30% |